This study is designed to estimate the effect of fluconazole (200 mg BID for 2 days), a
moderate CYP3A4 inhibitor on the pharmacokinetics of a single 8 mg oral dose of fesoterodine
in healthy adult subjects.
Drug: fesoterodine plus fluconazole
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT00911235
Ages eligible for Study
18 Years to 55 Years
Genders eligible for Study
Accepts Healthy Volunteers
Healthy subjects between the ages of 18 and 55 years
Not healthy subjects. subjects with acute or chronic medical or psychiatric condition or laboratory abnormality
All locations for NCT00911235
United States (1)
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511
View full eligibility
Tris trial is registered with FDA with number: NCT00911235. The sponsor of the trial is Pfizer and it is looking for 28 volunteers for the current phase.
Official trial title: An Open-Label, Randomized, Two-Way Crossover Study To Evaluate The Effect Of Fluconazole, A Moderate CYP3A4 Inhibitor, On The Single-Dose Pharmacokinetics Of Fesoterodine In Healthy Subjects.
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!